Global Alopecia Treatment Market to Reach US$ 4.8 Billion by 2032, Fostered by Growing Preference for Non-Invasive Treatment

April 14, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Alopecia Treatment Market Report by Drug Type (Minoxidil, Finasteride, and Others), Indication (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, and Others), Gender (Male, Female), Route of Administration (Oral, Topical, Injectable), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), and Region 2024-2032," the global alopecia treatment market size reached US$ 3.3 Billion in 2023. Alopecia is a medical condition characterized by hair loss, which can occur on the scalp or other parts of the body. It is caused due to several factors, including a sedentary lifestyle, unhealthy eating habits, and growing stress levels. Its treatment is dependent on numerous factors, such as the type of alopecia areata, patient age, and the extent of hair loss. The treatment aims to block the immune system attack and stimulate the regrowth of hair. Various drugs and surgical treatment options, including hair transplantation and scalp reduction, have been widely adopted for the treatment of alopecia. Besides, medications including minoxidil or finasteride are also used for baldness. These medications are formulated to stimulate hair growth or prevent further hair loss. Besides, phototherapy or low light laser therapy (LLLT) is gaining traction around the world as it is safer, tolerable, and less invasive than other treatments. 

Global Alopecia Treatment Market Trends:

The increasing prevalence of alopecia among the masses is driving the global market. Coupled with this, the rising cases of polycystic ovary syndrome (PCOS) are contributing to the overall growth of the market. In line with this, stressful lifestyles, the escalating cases of malnutrition, and the rising number of individuals with certain medical conditions, such as diabetes, lupus, and persistent weight loss, are catalyzing the increasing risk of hair loss. Moreover, the growing awareness about hair loss and the availability of various treatment options is impacting the market favorably. Besides, the availability of advanced treatment options, including platelet-rich plasma (PRP) therapy, mesotherapy, and low-level laser therapy (LLLT)are acting as another growth-inducing factor. Along with this, the increasing availability of products, including shampoos, conditioners, and other hair care products that claim to prevent hair loss and promote hair growth is also contributing to the growth of the alopecia treatment market. Additionally, the introduction of laser caps, helmets, combs, and bands are influencing the market. Furthermore, several key players are heavily investing in research and development activities to develop novel treatment options, thus providing a boost to the market. Apart from this, the increasing availability of advanced treatment options such as stem cell therapy and gene therapy is creating a positive market outlook. The market is further driven by other factors, such as the increasing availability of advanced treatment options, continuous improvements in healthcare infrastructure, and increasing concerns among parents about the health of their children. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. 

Market Summary:

  • On the basis of the drug type, the market has been segregated into minoxidil, finasteride and others.
  • Based on the indication, the market has been segmented into androgenic alopecia, alopecia areata, alopecia totalis and others.
  • On the basis of gender, the market has been bifurcated into male and female.
  • Based on the route of administration, the market has been classified into oral, topical, and injectable.
  • On the basis of the distribution channel, the market has been categorized into hospitals, retail pharmacies and online pharmacies.
  • Based on the region, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa. 
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd and Teva Pharmaceutical Industries Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Drug Type, Indication, Gender, Route of Administration, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd and Teva Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Alopecia Treatment Market to Reach US$ 4.8 Billion by 2032, Fostered by Growing Preference for Non-Invasive Treatment
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More